510(k) Report

510(k) · Cleared

Cleared

CROSSLEAD Standard 035 and CROSSLEAD Stiff 035

K261281510(k) TraditionalCleared Sep 3, 2026139-day reviewClass II21 CFR 870.1330

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Filmecc Co., Ltd. · DQX Wire, Guide, Catheter

Cleared on Sep 3, 2026 as substantially equivalent to K213315 (Asahi Intecc Co., Ltd., 2022) and 2 other predicates after a 139-day review. Its family tree reaches back 3 generations to 1986.

Decided
Sep 3, 2026
Review
139 days
Class
Class II
Product code
DQX
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K863138 (1986). 4 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK863138 Terumo Radifocus Guide WireTerumo Medical Corp. · 1986
  2. 2 generations backK063372 Radifocus Glidewire AdvantageTerumo Medical Corp. · 2007
  3. 1 generation backK213315 CROSSLEAD Peripheral Guide WireAsahi Intecc Co., Ltd. · 2022
  4. This deviceK261281 CROSSLEAD Standard 035 and CROSSLEAD Stiff 035Filmecc Co., Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K863138Terumo Radifocus Guide WireTerumo Medical Corp.1986—
−2K063372Radifocus Glidewire AdvantageTerumo Medical Corp.2007—
−1K213315CROSSLEAD Peripheral Guide WireAsahi Intecc Co., Ltd.2022—
0 (this device)K261281CROSSLEAD Standard 035 and CROSSLEAD Stiff 035Filmecc Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K261281, 1986–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQX device

  1. #1 K213854 SavvyWirescore 15.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K213315CROSSLEAD Peripheral Guide Wire
Summary page 5
…Classification Name: Catheter, Guide, Wire Product Code: DQX – Catheter Guide Wire Predicate Device: CROSSLEAD Peripheral Guide Wire (K213315) Terumo Radifocus Guidewire (K863138/K152740) Reference Devices: VAS…
Asahi Intecc Co., Ltd.2022—
*K863138Terumo Radifocus Guide Wire
Summary page 5
…DQX – Catheter Guide Wire Predicate Device: CROSSLEAD Peripheral Guide Wire (K213315) Terumo Radifocus Guidewire (K863138/K152740) Reference Devices: VASSALLO GT Crossing 14 (K232574) Indication For Use/Intended Use:…
Terumo Medical Corp.1986—
*K152740Radifocus Glidewire
Summary page 5
…DQX – Catheter Guide Wire Predicate Device: CROSSLEAD Peripheral Guide Wire (K213315) Terumo Radifocus Guidewire (K863138/K152740) Reference Devices: VASSALLO GT Crossing 14 (K232574) Indication For Use/Intended Use: Th…
Ashitaka Factory of Terumo Corp.2015—
†K232574VASSALLO GT Crossing14Filmec Co., Ltd.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 40 years and passes through 3 companies; a new generation was cleared every 15.4 years on median.
  • None of the 4 ancestors has a recall.

How does its category compare?

All DQX devices

DQX Wire, Guide, Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · DQX

10in 2025

2007: 142008: 192009: 182010: 212011: 182012: 202013: 182014: 182015: 152016: 142017: 192018: 192019: 132020: 142021: 62022: 152023: 102024: 112025: 102026 (partial year): 12
2007high 21 (2010) · low 6 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQX

177in 2025

2007: 85 days median2008: 87 days median2009: 87 days median2010: 63 days median2011: 43 days median2012: 62 days median2013: 119 days median2014: 103 days median2015: 112 days median2016: 179 days median2017: 85 days median2018: 114 days median2019: 173 days median2020: 106 days median2021: 161 days median2022: 212 days median2023: 136 days median2024: 134 days median2025: 177 days median2026 (partial year): 145 days median
2007high 212 (2022) · low 43 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQX

3in 2024

2007: 122008: 72009: 492010: 342011: 32012: 52013: 7, 4 Class I2015: 12016: 2, 2 Class I2017: 172018: 92019: 22020: 1, 1 Class I2024: 32026 (partial year): 4, 1 Class I
2007high 49 (2009) · low 0 (2014)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · DQX

2,178in 2025

2007: 7602008: 7152009: 6872010: 9872011: 1,3112012: 1,3372013: 1,4742014: 1,3232015: 1,3232016: 1,4662017: 1,5242018: 1,7372019: 1,6792020: 1,5362021: 1,7132022: 1,6472023: 2,0682024: 2,2102025: 2,178
2007high 2,210 (2024) · low 687 (2009)2025

MAUDE reports naming product code DQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007148512760
200819877715
2009188749687
2010216334987
2011184331,311
2012206251,337
2013181197 (4)1,474
20141810301,323
20151511211,323
2016141792 (2)1,466
20171985171,524
20181911491,737
20191317321,679
2020141061 (1)1,536
2021616101,713
20221521201,647
20231013602,068
20241113432,210
20251017702,178
2026121454 (1)—

What is it indicated for?

This product is designed to direct a catheter to the desired anatomical location in the peripheral vasculature during diagnostic or interventional procedures. This device is intended for peripheral vascular use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K261281: CROSSLEAD Standard 035 and CROSSLEAD Stiff 035.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K261281

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026